Purple Biotech Ltd (TLV:PPBT)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.100
0.00 (0.00%)
At close: Jan 29, 2026
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 20.44 million as of January 30, 2026. Its market cap has decreased by -46.58% in one year.
Market Cap
20.44M
Enterprise Value
-13.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.10
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 20.44M, an increase of 14.37%. That is a compound annual growth rate of 1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 20.44M | -8.33% |
| Dec 31, 2025 | 22.30M | -44.71% |
| Dec 31, 2024 | 40.34M | -48.30% |
| Dec 31, 2023 | 78.02M | -17.30% |
| Dec 29, 2022 | 94.35M | -55.64% |
| Dec 30, 2021 | 212.71M | -1.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 478.85M |
| Geffen Residence & Renewal | 258.75M |
| Matricelf | 154.29M |
| Clal Biotechnology Industries | 47.37M |
| BioLineRx | 41.77M |
| BioLight Life Sciences | 35.39M |
| Evogene | 28.50M |
| XTL Biopharmaceuticals | 25.55M |